CD133 Antisense Suppresses Cancer Cell Growth and Increases Sensitivity to Cisplatin in Vitro

Experimental and Therapeutic Medicine - Greece
doi 10.3892/etm.2012.692
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

SOX17 Increases the Cisplatin Sensitivity of an Endometrial Cancer Cell Line

Cancer Cell International
Cancer ResearchOncologyGenetics
2016English

Association of ATP7A Expression and in Vitro Sensitivity to Cisplatin in Non-Small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2010English

Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133+ Cell Populations and Suppressing ERK/P70S6K Signaling

Scientific Reports
Multidisciplinary
2015English

Targeted TPX2 Increases Chromosome Missegregation and Suppresses Tumor Cell Growth in Human Prostate Cancer

OncoTargets and Therapy
OncologyPharmacology
2017English

miR-154 Suppresses Non-Small Cell Lung Cancer Growth in Vitro and in Vivo

Oncology Reports
MedicineCancer ResearchOncology
2015English

A Novel Human in Vitro Papillomavirus Type 16 Positive Tonsil Cancer Cell Line With High Sensitivity to Radiation and Cisplatin

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

MiR-30a-5p Antisense Oligonucleotide Suppresses Glioma Cell Growth by Targeting SEPT7

PLoS ONE
Multidisciplinary
2013English

ErbB3 Expression Predicts Sensitivity to Elisidepsin Treatment: In�vitro Synergism With Cisplatin, Paclitaxel and Gemcitabine in Lung, Breast and Colon Cancer Cell Lines

International Journal of Oncology
Cancer ResearchOncology
2012English

PJ34, an Inhibitor of PARP-1, Suppresses Cell Growth and Enhances the Suppressive Effects of Cisplatin in Liver Cancer Cells

Oncology Reports
MedicineCancer ResearchOncology
1994English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy